Trax Surgical has completed the first patient procedure using its REDIFIX suture anchor system, following recent regulatory clearance in the United States.

The Massachusetts-based orthopaedic product development and distribution company used the REDIFIX implant during a mid-foot reconstruction procedure. According to the company, surgeons reported that the system provided simple placement, reduction and fixation, while also offering strong procedural control.

Trax Surgical received U.S. Food and Drug Administration 510(k) clearance for the REDIFIX Suture Anchor System in late April 2026.

The REDIFIX system includes a cannulated threaded distal implant connected to a proximal implant through a high-strength suture loop and a sliding knot mechanism. During the procedure, a guidewire is first positioned, followed by drilling of a pilot hole before the implant is inserted over the wire. The proximal implant and surrounding tissues are then reduced by applying traction to the suture.

The company stated that the system has the potential to support a broad range of orthopaedic procedures as it continues to work with surgeons on future clinical applications.

 

Source: prnewswire.com

Report Abuse